carbamates has been researched along with E coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correia, VG | 1 |
| Bonifácio, VD | 1 |
| Raje, VP | 1 |
| Casimiro, T | 1 |
| Moutinho, G | 1 |
| da Silva, CL | 1 |
| Pinho, MG | 1 |
| Aguiar-Ricardo, A | 1 |
| Li, HQ | 1 |
| Luo, Y | 1 |
| Zhu, HL | 1 |
2 other studies available for carbamates and E coli Infections
| Article | Year |
|---|---|
Oxazoline-based antimicrobial oligomers: synthesis by CROP using supercritical CO2.
Topics: Anti-Bacterial Agents; Aziridines; Carbamates; Carbon Dioxide; Escherichia coli; Escherichia coli In | 2011 |
Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Anti-Bacterial Agents; Carbamates; Drug Design; Enzyme In | 2011 |